Ixico

IXI:LNLondon Stock Exchange

Overview

Company Profile

Since 2004, we have been dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of new therapies for neurological diseases through the application of medical image analysis, bringing safe and effective treatment to patients sooner. We are committed to advancing imaging biomarkers in CNS therapeutic areas such as Huntington’s disease, Parkinson’s disease and Alzheimer’s disease.

Classification

SectorHealthcare
ExchangeLondon Stock Exchange
IndustryBiotechnology & Life Sciences